XML 52 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Changes in Shareholders’ Equity - USD ($)
$ in Millions
Total
Total shareholders' equity attributable to common shareholders
Common shares
Additional paid-in capital
Accumulated other comprehensive loss, net of tax
Unrealized losses on available-for-sale securities, net of tax
Currency translation reserve
Retained earnings/(accumulated deficit)
Non-controlling interests
Balance - beginning of year at Dec. 31, 2020     $ 1.9 $ 2,072.1   $ 22.4 $ 0.2 $ (120.4) $ 0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock repurchased during period     (0.2) (320.7)          
Issue of common shares     0.2 318.0          
Dividends, common stock, cash       0.0         (2.6)
Shares cancelled upon distribution of Fidelis MGU     0.0            
Share compensation expense       9.8          
Shares withheld for employee taxes on restricted stock vesting       0.0          
Net income $ 78.3             68.3 10.0
Distribution of Fidelis MGU net assets to shareholders       0.0       0.0 0.0
Purchase of non-controlling interest       (3.8)         0.0
Total income tax benefit/(expense) allocated to comprehensive income (33.9)         (33.7) (0.2)    
Non-controlling interest arising from sale of a subsidiary                 (2.2)
Balance – end of year at Dec. 31, 2021 2,019.1 $ 2,013.9 1.9 2,075.4 $ (11.3) (11.3) 0.0 (52.1) 5.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock repurchased during period     0.0 0.0          
Issue of common shares     0.0 0.0          
Dividends, common stock, cash       0.0         (3.9)
Shares cancelled upon distribution of Fidelis MGU     0.0            
Share compensation expense       10.8          
Shares withheld for employee taxes on restricted stock vesting       0.0          
Net income 62.3             52.6 9.7
Distribution of Fidelis MGU net assets to shareholders       0.0       0.0 0.0
Purchase of non-controlling interest       (11.0)         (0.7)
Total income tax benefit/(expense) allocated to comprehensive income (89.5)         (88.4) (1.1)    
Non-controlling interest arising from sale of a subsidiary                 0.0
Balance – end of year at Dec. 31, 2022 1,987.1 1,976.8 1.9 2,075.2 (100.8) (99.7) (1.1) 0.5 10.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock repurchased during period     0.0 0.0          
Issue of common shares     0.2 89.3          
Dividends, common stock, cash       (34.1)         0.0
Shares cancelled upon distribution of Fidelis MGU     (0.9)            
Share compensation expense       27.6          
Shares withheld for employee taxes on restricted stock vesting       (50.6)          
Net income 2,132.5             2,132.5 0.0
Distribution of Fidelis MGU net assets to shareholders       (68.4)       (1,696.4) (10.3)
Purchase of non-controlling interest       0.0         0.0
Total income tax benefit/(expense) allocated to comprehensive income 72.7         72.7 1.1    
Non-controlling interest arising from sale of a subsidiary                 0.0
Balance – end of year at Dec. 31, 2023 $ 2,449.8 $ 2,449.8 $ 1.2 $ 2,039.0 $ (27.0) $ (27.0) $ 0.0 $ 436.6 $ 0.0